The United States government has a history of handing down favorable policies to Monsanto and their products, including the ubiquitous Roundup weedkiller.
The product contains glyphosate as its main ingredient, which the World Health Organization recently called a probable human carcinogen.
Now following the ruling the company has been forced to deal with an onslaught of new challenges from scientists, consumer and activists demanding better regulations.
Recently a column published in the New England Journal of Medicine accused U.S. regulators of using “flawed and outdated research” to allow the use of glyphosate, and called for new assessments to be “urgently conducted” according to this article on the website GMWatch.org.
Protecting Human Health
As noted in this major study and others, GMOs have led to the ramping up of glyphosate as a means to kill pests on crops.
But that increase in pesticide use has led to glyphosate spreading throughout the environment, causing harm to both plant and animal life. The column notes that new regulatory action is necessary to protect human health because of this increase in pesticide use.
That increase combined with the WHO report on glyphosate and cancer has them concerned for the health of the U.S. population, something they say the EPA is not taking seriously.
The opinion piece, written by Dr. Philip Landrigan, a Harvard-educated pediatrician and epidemiologist who is Dean for Global Health at the Mount Sinai Medical Center in New York, and Charles Benbrook, author of the above study, argues that the combo of GMOs and the chemicals applied may pose “hazards to human health” that previous regulatory bodies have not properly assessed.
Also claimed in the article is that outdated studies have been used to applies such chemicals and that the studies were commissioned by the manufacturers of the chemicals themselves.
For more on this topic, you can check out the original article at GMWatch.org.
Nick Meyer writes for MAM and the website AltHealthWORKS.com.